This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pinto, L. A.
Right arrow Articles by Shearer, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pinto, L. A.
Right arrow Articles by Shearer, G. M.

 Previous Article  |  Next Article 

Journal of Virology, May 2000, p. 4505-4511, Vol. 74, No. 10
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Inhibition of Human Immunodeficiency Virus Type 1 Replication prior to Reverse Transcription by Influenza Virus Stimulation

Ligia A. Pinto,1 Vesna Blazevic,1 Bruce K. Patterson,2 C. Mac Trubey,3 Matthew J. Dolan,4 and Gene M. Shearer1,*

Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda,1 andIntramural Research Support Program, SAIC Frederick, NCI-FCRDC, Frederick,3 Maryland; Laboratory of Viral Pathogenesis, Northwestern University Medical School, Chicago, Illinois2; and Wilford Hall Medical Center, Lackland AFB, Texas4

Received 27 September 1999/Accepted 11 February 2000

It is now recognized that, in addition to drug-mediated therapies against human immunodeficiency virus type 1 (HIV-1), the immune system can exert antiviral effects via CD8+ T-cell-generated anti-HIV factors. This study demonstrates that (i) supernatants from peripheral blood mononuclear cells (PBMC) stimulated with influenza A virus inhibit replication of CCR5- and CXCR4-tropic HIV-1 isolates prior to reverse transcription; (ii) the HIV-suppressive supernatants can be generated by CD4- or CD8-depleted PBMC; (iii) this anti-HIV activity is partially due to alpha interferon (IFN-alpha ), but not to IFN-gamma , IFN-beta , the beta -chemokines MIP-1alpha , MIP-1beta , and RANTES, or interleukin-16; (iv) the anti-HIV activity is generated equally well by PBMC cultured with either infectious or UV-inactivated influenza A virus; and (v) the antiviral activity can be generated by influenza A-stimulated PBMC from HIV-infected individuals. These findings represent a novel mechanism for inhibition of HIV-1 replication that differs from the previously described CD8 anti-HIV factors (MIP-1alpha , MIP-1beta , RANTES, and CD8 antiviral factor).

* Corresponding author. Mailing address: Experimental Immunology Branch, National Institutes of Health, NCI, Bldg. 10, Rm. 4B36, Bethesda, MD 20892. Phone: (301) 402-3246. Fax: (301) 402-3643. E-mail: shearerg{at}exchange.nih.gov.

Journal of Virology, May 2000, p. 4505-4511, Vol. 74, No. 10
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Fakruddin, J. M., Lempicki, R. A., Gorelick, R. J., Yang, J., Adelsberger, J. W., Garcia-Pineres, A. J., Pinto, L. A., Lane, H. C., Imamichi, T. (2007). Noninfectious papilloma virus-like particles inhibit HIV-1 replication: implications for immune control of HIV-1 infection by IL-27. Blood 109: 1841-1849 [Abstract] [Full Text]  
  • Pilotti, E., Elviri, L., Vicenzi, E., Bertazzoni, U., Re, M. C., Allibardi, S., Poli, G., Casoli, C. (2007). Postgenomic up-regulation of CCL3L1 expression in HTLV-2-infected persons curtails HIV-1 replication. Blood 109: 1850-1856 [Abstract] [Full Text]  
  • Gould, S. J., Booth, A. M., Hildreth, J. E. K. (2003). The Trojan exosome hypothesis. Proc. Natl. Acad. Sci. USA 100: 10592-10597 [Abstract] [Full Text]  
  • Mazzoni, A., Leifer, C. A., Mullen, G. E. D., Kennedy, M. N., Klinman, D. M., Segal, D. M. (2003). Cutting Edge: Histamine Inhibits IFN-{alpha} Release from Plasmacytoid Dendritic Cells. J. Immunol. 170: 2269-2273 [Abstract] [Full Text]  
  • Rice, J., Connor, R., Worgall, S., Moore, J. P., Leopold, P. L., Kaner, R. J., Crystal, R. G. (2002). Inhibition of HIV-1 Replication in Alveolar Macrophages by Adenovirus Gene Transfer Vectors. Am. J. Respir. Cell Mol. Bio. 27: 214-219 [Abstract] [Full Text]  
  • Chang, T. L.-Y., Mosoian, A., Pine, R., Klotman, M. E., Moore, J. P. (2002). A Soluble Factor(s) Secreted from CD8+ T Lymphocytes Inhibits Human Immunodeficiency Virus Type 1 Replication through STAT1 Activation. J. Virol. 76: 569-581 [Abstract] [Full Text]  
  • Xiang, J., Wunschmann, S., Diekema, D. J., Klinzman, D., Patrick, K. D., George, S. L., Stapleton, J. T. (2001). Effect of Coinfection with GB Virus C on Survival among Patients with HIV Infection. NEJM 345: 707-714 [Abstract] [Full Text]  
  • Bahr, G. M., Darcissac, E. C. A., Casteran, N., Amiel, C., Cocude, C., Truong, M.-J., Dewulf, J., Capron, A., Mouton, Y. (2001). Selective Regulation of Human Immunodeficiency Virus-Infected CD4+ Lymphocytes by a Synthetic Immunomodulator Leads to Potent Virus Suppression In Vitro and in hu-PBL-SCID Mice. J. Virol. 75: 6941-6952 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»